云峰药业品牌怎么样 申请店铺

我要投票 云峰药业在灵芝孢子粉行业中的票数:769 更新时间:2026-01-09
云峰药业是哪个国家的品牌?「云峰药业」是 贵州云峰药业有限公司 旗下著名品牌。该品牌发源于贵州省毕节地区,由创始人王瑞松在1999-01-20期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云峰药业品牌出海!将品牌入驻外推网,定制云峰药业品牌推广信息,可以显著提高云峰药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

云峰药业怎么样

贵州云峰药业有限公司,为广州云峰集团旗下骨干产业之一,成立于1999年,坐落于贵州省盘江流域兴义市,占地面积43556平方米,其中绿化面积超过54%,被业界称为花园式工厂。

公司为集药品、保健品研发、生产、营销于一体的现代化制药企业,拥有原料药合成、中药提取、固体制剂、鼻喷雾剂和保健食品5个生产车间,主要经营产品有:敏奇盐酸氮卓斯汀(原料药、片剂、鼻喷雾剂),小葫芦宝灵芝胶囊、复方板蓝根颗粒、消炎利胆片、黄柏胶囊、双黄消炎片、破壁灵芝孢子粉胶囊、脂康宝颗粒、灵芝茶等药品及保健品。

公司营销中心设在中国经济活跃带--广州,营销网络遍及全国。国家二类新药敏奇牌盐酸氮卓斯汀原料药及制剂在同类产品中占一定地位,灵芝系列产品市场潜力巨大。公司现有员工100余人,中专及以上学历占80%以上,中、高级专业技术人员约占20%;公司现有生产设备200余台套、出色的检验仪器30余台套,具备较强的生产和检验能力。

在新的发展时期,云峰药业将秉承诚实守信、以人为本、业绩导向、创新发展的核心价值观,以务实、专业、责任、协同的企业精神,以精制好药、关爱健康为企业使命,专注于成为消费者信赖和喜爱的制药企业,持续为社会、员工和股东创造价值,为黔西南州医药事业的发展再立新功。


Guizhou Yunfeng Pharmaceutical Co., Ltd., one of the backbone industries of Guangzhou Yunfeng group, was founded in 1999 and located in Xingyi City, Panjiang River Basin, Guizhou Province, covering an area of 43556 square meters, of which the greening area is more than 54%, known as the garden factory in the industry. The company is a modern pharmaceutical enterprise integrating research and development, production and marketing of medicines and health products. It has 5 production workshops, including raw material synthesis, Chinese medicine extraction, solid preparation, nasal spray and health food. The main products are: Min Qi hydrochloride, nitrogen Jostin (APIs, tablets, nasal spray), small bottle gourd, Ganoderma lucidum capsules, Fufang Banlangen Keli, Xiaoyan Li Dan tablets, and Cortex Phellodendri. Capsule, Shuanghuang Xiaoyan tablet, broken wall ganoderma spore powder capsule, zhikangbao granules, ganoderma tea and other drugs and health products. The company's marketing center is located in Guangzhou, China's economic active zone, and its marketing network covers the whole country. The raw materials and preparations of national second-class new drug Minqi brand azithromycin hydrochloride occupy a certain position in similar products, and the market potential of Ganoderma series products is huge. The company has more than 100 employees, more than 80% of them are technical secondary school or above, and about 20% of them are middle and senior professional technicians. The company has more than 200 sets of production equipment, more than 30 sets of excellent inspection instruments, and has strong production and inspection capabilities. In the new development period, Yunfeng pharmaceutical industry will uphold the core values of honesty, trustworthiness, people-oriented, performance-oriented, innovative development, with the corporate spirit of pragmatism, professionalism, responsibility and coordination, with the corporate mission of refining good medicine and caring for health, focus on becoming a pharmaceutical enterprise trusted and loved by consumers, continue to create value for the society, employees and shareholders, and provide medical services in Qianxi Nanzhou New achievements have been made in the development of medicine.

本文链接: https://brand.waitui.com/44727a1ae.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

福建铁路公司注册资本增至377.1亿,增幅约15%

36氪获悉,爱企查App显示,近日,福建铁路有限公司发生工商变更,注册资本由约328.1亿人民币增至约377.1亿人民币,增幅约15%。

2小时前

日联科技:已完成收购SSTI 66%股权

36氪获悉,日联科技公告,公司全资子公司新加坡瑞泰已按照协议约定支付本次交易的股权收购款,并取得 SSTI 66%股权,本次股权交割已完成。

2小时前

正海生物:公司取得医疗器械注册证

36氪获悉,正海生物公告,公司于近日取得国家药品监督管理局下发的《中华人民共和国医疗器械注册证》,产品名称为钙硅生物陶瓷口腔骨修复材料,注册证编号为国械注准20263170015,有效期至2031年1月6日。该产品适用于牙槽骨缺损修复,采用三维打印方式成型,具备定制化生产潜力。此注册证的取得将丰富公司口腔领域产品线,提升市场竞争力。但产品上市后实际销售情况取决于市场推广效果,对公司未来业绩的影响无法准确预测。

2小时前

闲鱼:2025年二次元、追星与游戏用户总量已突破1.6亿

36氪获悉,《2025闲鱼次元年度报告》显示,截至2025年底,闲鱼二次元、追星与游戏用户总量已突破1.6亿,年度二次元消费人数同比增长47%,平台已成为年轻人兴趣消费的首选阵地。

2小时前

绿地控股:预计2025年净亏损160亿元-190亿元

36氪获悉,绿地控股公告,预计2025年归属于母公司所有者的净利润为-190亿元到-160亿元。上年同期为-155.52亿元。受资产价格持续下行、公司加大促销去化力度、部分项目开发周期延长等多种因素的影响,基于谨慎性原则,公司对存在风险的存货拟计提减值准备;由于市场有效需求不足、社会预期偏弱,公司房地产业的结转规模、基建产业的营收规模同比均有较大幅度的下降,公司房地产业结转毛利率也同比下降,导致业绩进一步承压;房地产项目利息资本化减少,计入当期财务费用的利息支出增加。

2小时前

本页详细列出关于云峰药业的品牌信息,含品牌所属公司介绍,云峰药业所处行业的品牌地位及优势。
咨询